POINT Biopharma Global Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Indianapolis, IN
SEC filing record 1 source field available
Fiscal year end
31 December
POINT Biopharma Global Inc. has filed 285 SEC EDGAR filings since 14 May 2020

SEC filing history

Showing 1-11 of 11 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-91575

SC 13D/A

Filing date
27 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91575

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
20 Dec 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91575

SCHEDULE 13D

Filing date
06 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91575

SC 13D/A

Filing date
03 Oct 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91575

SC 13D/A

Filing date
22 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91575

SC 13D/A

Filing date
26 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91575

SC 13D/A

Filing date
16 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91575

POINT BIOPHARMA GLOBAL INC.

Filing date
29 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91575

SCHEDULE 13D/A

Filing date
14 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91575

SC 13D

Filing date
12 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91575

THERAPEUTICS ACQUISITION CORP.

Filing date
30 Jun 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .